ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Cholesterol Lowering Biologic Drugs Market Research Report 2025
Published Date: September 2025
|
Report Code: QYRE-Auto-22V9247
Home | Market Reports | Health| Health Conditions| Heart & Hypertension
Global Cholesterol Lowering Biologic Drugs Market Insights and Forecast to 2028
BUY CHAPTERS

Global Cholesterol Lowering Biologic Drugs Market Research Report 2025

Code: QYRE-Auto-22V9247
Report
September 2025
Pages:73
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Amgen Inc
Regeneron Pharmaceuticals
Alnylam Pharmaceuticals

Cholesterol Lowering Biologic Drugs Market Size

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years.

Cholesterol Lowering Biologic Drugs Market

Cholesterol Lowering Biologic Drugs Market

The global market for Cholesterol Lowering Biologic Drugs was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
The cholesterol lowering biologic drugs offers a new, revolutionary alternative for people fighting with cholesterol with the same old treatments. The old method of treating cholesterol elevated levels includes a change in diet and consuming statin pills to prevent the body from making more bad cholesterol. The new class of PCSK-9 inhibitors is being approved by the FDA which works by helping the liver flush out the bad cholesterol instead of preventing the body from making low-density lipoproteins. The FDA has till now approved only two drugs Praluent and Repatha, both made from living things. The PCSK-9 is a protein which binds to the receptors, those which are responsible for getting the bad cholesterol out of the body.
The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Cholesterol Lowering Biologic Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Cholesterol Lowering Biologic Drugs.
The Cholesterol Lowering Biologic Drugs market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Cholesterol Lowering Biologic Drugs market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Cholesterol Lowering Biologic Drugs manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Cholesterol Lowering Biologic Drugs Market Report

Report Metric Details
Report Name Cholesterol Lowering Biologic Drugs Market
CAGR 5%
Segment by Type
  • Oral
  • Injectable
Segment by Application
  • Hospital Pharmacies
  • Retail Pharmacies
  • Drug Stores
  • Online Sales
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Amgen, Regeneron Pharmaceuticals, Alnylam Pharmaceuticals
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Cholesterol Lowering Biologic Drugs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Cholesterol Lowering Biologic Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

Who are the main players in the Cholesterol Lowering Biologic Drugs Market report?

Ans: The main players in the Cholesterol Lowering Biologic Drugs Market are Amgen, Regeneron Pharmaceuticals, Alnylam Pharmaceuticals

What are the Application segmentation covered in the Cholesterol Lowering Biologic Drugs Market report?

Ans: The Applications covered in the Cholesterol Lowering Biologic Drugs Market report are Hospital Pharmacies, Retail Pharmacies, Drug Stores, Online Sales

What are the Type segmentation covered in the Cholesterol Lowering Biologic Drugs Market report?

Ans: The Types covered in the Cholesterol Lowering Biologic Drugs Market report are Oral, Injectable

1 Cholesterol Lowering Biologic Drugs Market Overview
1.1 Product Definition
1.2 Cholesterol Lowering Biologic Drugs by Type
1.2.1 Global Cholesterol Lowering Biologic Drugs Market Value Comparison by Type (2024 VS 2031)
1.2.2 Oral
1.2.3 Injectable
1.3 Cholesterol Lowering Biologic Drugs by Application
1.3.1 Global Cholesterol Lowering Biologic Drugs Market Value by Application (2024 VS 2031)
1.3.2 Hospital Pharmacies
1.3.3 Retail Pharmacies
1.3.4 Drug Stores
1.3.5 Online Sales
1.4 Global Cholesterol Lowering Biologic Drugs Market Size Estimates and Forecasts
1.4.1 Global Cholesterol Lowering Biologic Drugs Revenue 2020-2031
1.4.2 Global Cholesterol Lowering Biologic Drugs Sales 2020-2031
1.4.3 Global Cholesterol Lowering Biologic Drugs Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Cholesterol Lowering Biologic Drugs Market Competition by Manufacturers
2.1 Global Cholesterol Lowering Biologic Drugs Sales Market Share by Manufacturers (2020-2025)
2.2 Global Cholesterol Lowering Biologic Drugs Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Cholesterol Lowering Biologic Drugs Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Cholesterol Lowering Biologic Drugs, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Cholesterol Lowering Biologic Drugs, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Cholesterol Lowering Biologic Drugs, Product Type & Application
2.7 Global Key Manufacturers of Cholesterol Lowering Biologic Drugs, Date of Enter into This Industry
2.8 Global Cholesterol Lowering Biologic Drugs Market Competitive Situation and Trends
2.8.1 Global Cholesterol Lowering Biologic Drugs Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Cholesterol Lowering Biologic Drugs Players Market Share by Revenue
2.8.3 Global Cholesterol Lowering Biologic Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Cholesterol Lowering Biologic Drugs Market Scenario by Region
3.1 Global Cholesterol Lowering Biologic Drugs Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Cholesterol Lowering Biologic Drugs Sales by Region: 2020-2031
3.2.1 Global Cholesterol Lowering Biologic Drugs Sales by Region: 2020-2025
3.2.2 Global Cholesterol Lowering Biologic Drugs Sales by Region: 2026-2031
3.3 Global Cholesterol Lowering Biologic Drugs Revenue by Region: 2020-2031
3.3.1 Global Cholesterol Lowering Biologic Drugs Revenue by Region: 2020-2025
3.3.2 Global Cholesterol Lowering Biologic Drugs Revenue by Region: 2026-2031
3.4 North America Cholesterol Lowering Biologic Drugs Market Facts & Figures by Country
3.4.1 North America Cholesterol Lowering Biologic Drugs Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Cholesterol Lowering Biologic Drugs Sales by Country (2020-2031)
3.4.3 North America Cholesterol Lowering Biologic Drugs Revenue by Country (2020-2031)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Cholesterol Lowering Biologic Drugs Market Facts & Figures by Country
3.5.1 Europe Cholesterol Lowering Biologic Drugs Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Cholesterol Lowering Biologic Drugs Sales by Country (2020-2031)
3.5.3 Europe Cholesterol Lowering Biologic Drugs Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Cholesterol Lowering Biologic Drugs Market Facts & Figures by Region
3.6.1 Asia Pacific Cholesterol Lowering Biologic Drugs Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Cholesterol Lowering Biologic Drugs Sales by Region (2020-2031)
3.6.3 Asia Pacific Cholesterol Lowering Biologic Drugs Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Cholesterol Lowering Biologic Drugs Market Facts & Figures by Country
3.7.1 Latin America Cholesterol Lowering Biologic Drugs Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Cholesterol Lowering Biologic Drugs Sales by Country (2020-2031)
3.7.3 Latin America Cholesterol Lowering Biologic Drugs Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Cholesterol Lowering Biologic Drugs Market Facts & Figures by Country
3.8.1 Middle East and Africa Cholesterol Lowering Biologic Drugs Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Cholesterol Lowering Biologic Drugs Sales by Country (2020-2031)
3.8.3 Middle East and Africa Cholesterol Lowering Biologic Drugs Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Cholesterol Lowering Biologic Drugs Sales by Type (2020-2031)
4.1.1 Global Cholesterol Lowering Biologic Drugs Sales by Type (2020-2025)
4.1.2 Global Cholesterol Lowering Biologic Drugs Sales by Type (2026-2031)
4.1.3 Global Cholesterol Lowering Biologic Drugs Sales Market Share by Type (2020-2031)
4.2 Global Cholesterol Lowering Biologic Drugs Revenue by Type (2020-2031)
4.2.1 Global Cholesterol Lowering Biologic Drugs Revenue by Type (2020-2025)
4.2.2 Global Cholesterol Lowering Biologic Drugs Revenue by Type (2026-2031)
4.2.3 Global Cholesterol Lowering Biologic Drugs Revenue Market Share by Type (2020-2031)
4.3 Global Cholesterol Lowering Biologic Drugs Price by Type (2020-2031)
5 Segment by Application
5.1 Global Cholesterol Lowering Biologic Drugs Sales by Application (2020-2031)
5.1.1 Global Cholesterol Lowering Biologic Drugs Sales by Application (2020-2025)
5.1.2 Global Cholesterol Lowering Biologic Drugs Sales by Application (2026-2031)
5.1.3 Global Cholesterol Lowering Biologic Drugs Sales Market Share by Application (2020-2031)
5.2 Global Cholesterol Lowering Biologic Drugs Revenue by Application (2020-2031)
5.2.1 Global Cholesterol Lowering Biologic Drugs Revenue by Application (2020-2025)
5.2.2 Global Cholesterol Lowering Biologic Drugs Revenue by Application (2026-2031)
5.2.3 Global Cholesterol Lowering Biologic Drugs Revenue Market Share by Application (2020-2031)
5.3 Global Cholesterol Lowering Biologic Drugs Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Amgen
6.1.1 Amgen Company Information
6.1.2 Amgen Description and Business Overview
6.1.3 Amgen Cholesterol Lowering Biologic Drugs Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Amgen Cholesterol Lowering Biologic Drugs Product Portfolio
6.1.5 Amgen Recent Developments/Updates
6.2 Regeneron Pharmaceuticals
6.2.1 Regeneron Pharmaceuticals Company Information
6.2.2 Regeneron Pharmaceuticals Description and Business Overview
6.2.3 Regeneron Pharmaceuticals Cholesterol Lowering Biologic Drugs Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Regeneron Pharmaceuticals Cholesterol Lowering Biologic Drugs Product Portfolio
6.2.5 Regeneron Pharmaceuticals Recent Developments/Updates
6.3 Alnylam Pharmaceuticals
6.3.1 Alnylam Pharmaceuticals Company Information
6.3.2 Alnylam Pharmaceuticals Description and Business Overview
6.3.3 Alnylam Pharmaceuticals Cholesterol Lowering Biologic Drugs Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Alnylam Pharmaceuticals Cholesterol Lowering Biologic Drugs Product Portfolio
6.3.5 Alnylam Pharmaceuticals Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Cholesterol Lowering Biologic Drugs Industry Chain Analysis
7.2 Cholesterol Lowering Biologic Drugs Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Cholesterol Lowering Biologic Drugs Production Mode & Process Analysis
7.4 Cholesterol Lowering Biologic Drugs Sales and Marketing
7.4.1 Cholesterol Lowering Biologic Drugs Sales Channels
7.4.2 Cholesterol Lowering Biologic Drugs Distributors
7.5 Cholesterol Lowering Biologic Drugs Customer Analysis
8 Cholesterol Lowering Biologic Drugs Market Dynamics
8.1 Cholesterol Lowering Biologic Drugs Industry Trends
8.2 Cholesterol Lowering Biologic Drugs Market Drivers
8.3 Cholesterol Lowering Biologic Drugs Market Challenges
8.4 Cholesterol Lowering Biologic Drugs Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
FEATURED COMPANIES
Amgen Inc
Regeneron Pharmaceuticals
Alnylam Pharmaceuticals
List of Tables
 Table 1. Global Cholesterol Lowering Biologic Drugs Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global Cholesterol Lowering Biologic Drugs Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global Cholesterol Lowering Biologic Drugs Market Competitive Situation by Manufacturers in 2024
 Table 4. Global Cholesterol Lowering Biologic Drugs Sales (K Units) of Key Manufacturers (2020-2025)
 Table 5. Global Cholesterol Lowering Biologic Drugs Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global Cholesterol Lowering Biologic Drugs Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global Cholesterol Lowering Biologic Drugs Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market Cholesterol Lowering Biologic Drugs Average Price (USD/Unit) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of Cholesterol Lowering Biologic Drugs, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Cholesterol Lowering Biologic Drugs, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Cholesterol Lowering Biologic Drugs, Product Type & Application
 Table 12. Global Key Manufacturers of Cholesterol Lowering Biologic Drugs, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Cholesterol Lowering Biologic Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cholesterol Lowering Biologic Drugs as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Cholesterol Lowering Biologic Drugs Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global Cholesterol Lowering Biologic Drugs Sales by Region (2020-2025) & (K Units)
 Table 18. Global Cholesterol Lowering Biologic Drugs Sales Market Share by Region (2020-2025)
 Table 19. Global Cholesterol Lowering Biologic Drugs Sales by Region (2026-2031) & (K Units)
 Table 20. Global Cholesterol Lowering Biologic Drugs Sales Market Share by Region (2026-2031)
 Table 21. Global Cholesterol Lowering Biologic Drugs Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global Cholesterol Lowering Biologic Drugs Revenue Market Share by Region (2020-2025)
 Table 23. Global Cholesterol Lowering Biologic Drugs Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global Cholesterol Lowering Biologic Drugs Revenue Market Share by Region (2026-2031)
 Table 25. North America Cholesterol Lowering Biologic Drugs Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America Cholesterol Lowering Biologic Drugs Sales by Country (2020-2025) & (K Units)
 Table 27. North America Cholesterol Lowering Biologic Drugs Sales by Country (2026-2031) & (K Units)
 Table 28. North America Cholesterol Lowering Biologic Drugs Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America Cholesterol Lowering Biologic Drugs Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe Cholesterol Lowering Biologic Drugs Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe Cholesterol Lowering Biologic Drugs Sales by Country (2020-2025) & (K Units)
 Table 32. Europe Cholesterol Lowering Biologic Drugs Sales by Country (2026-2031) & (K Units)
 Table 33. Europe Cholesterol Lowering Biologic Drugs Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe Cholesterol Lowering Biologic Drugs Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific Cholesterol Lowering Biologic Drugs Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific Cholesterol Lowering Biologic Drugs Sales by Region (2020-2025) & (K Units)
 Table 37. Asia Pacific Cholesterol Lowering Biologic Drugs Sales by Region (2026-2031) & (K Units)
 Table 38. Asia Pacific Cholesterol Lowering Biologic Drugs Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific Cholesterol Lowering Biologic Drugs Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Cholesterol Lowering Biologic Drugs Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America Cholesterol Lowering Biologic Drugs Sales by Country (2020-2025) & (K Units)
 Table 42. Latin America Cholesterol Lowering Biologic Drugs Sales by Country (2026-2031) & (K Units)
 Table 43. Latin America Cholesterol Lowering Biologic Drugs Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Cholesterol Lowering Biologic Drugs Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa Cholesterol Lowering Biologic Drugs Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa Cholesterol Lowering Biologic Drugs Sales by Country (2020-2025) & (K Units)
 Table 47. Middle East and Africa Cholesterol Lowering Biologic Drugs Sales by Country (2026-2031) & (K Units)
 Table 48. Middle East and Africa Cholesterol Lowering Biologic Drugs Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa Cholesterol Lowering Biologic Drugs Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global Cholesterol Lowering Biologic Drugs Sales (K Units) by Type (2020-2025)
 Table 51. Global Cholesterol Lowering Biologic Drugs Sales (K Units) by Type (2026-2031)
 Table 52. Global Cholesterol Lowering Biologic Drugs Sales Market Share by Type (2020-2025)
 Table 53. Global Cholesterol Lowering Biologic Drugs Sales Market Share by Type (2026-2031)
 Table 54. Global Cholesterol Lowering Biologic Drugs Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global Cholesterol Lowering Biologic Drugs Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global Cholesterol Lowering Biologic Drugs Revenue Market Share by Type (2020-2025)
 Table 57. Global Cholesterol Lowering Biologic Drugs Revenue Market Share by Type (2026-2031)
 Table 58. Global Cholesterol Lowering Biologic Drugs Price (USD/Unit) by Type (2020-2025)
 Table 59. Global Cholesterol Lowering Biologic Drugs Price (USD/Unit) by Type (2026-2031)
 Table 60. Global Cholesterol Lowering Biologic Drugs Sales (K Units) by Application (2020-2025)
 Table 61. Global Cholesterol Lowering Biologic Drugs Sales (K Units) by Application (2026-2031)
 Table 62. Global Cholesterol Lowering Biologic Drugs Sales Market Share by Application (2020-2025)
 Table 63. Global Cholesterol Lowering Biologic Drugs Sales Market Share by Application (2026-2031)
 Table 64. Global Cholesterol Lowering Biologic Drugs Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global Cholesterol Lowering Biologic Drugs Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global Cholesterol Lowering Biologic Drugs Revenue Market Share by Application (2020-2025)
 Table 67. Global Cholesterol Lowering Biologic Drugs Revenue Market Share by Application (2026-2031)
 Table 68. Global Cholesterol Lowering Biologic Drugs Price (USD/Unit) by Application (2020-2025)
 Table 69. Global Cholesterol Lowering Biologic Drugs Price (USD/Unit) by Application (2026-2031)
 Table 70. Amgen Company Information
 Table 71. Amgen Description and Business Overview
 Table 72. Amgen Cholesterol Lowering Biologic Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 73. Amgen Cholesterol Lowering Biologic Drugs Product
 Table 74. Amgen Recent Developments/Updates
 Table 75. Regeneron Pharmaceuticals Company Information
 Table 76. Regeneron Pharmaceuticals Description and Business Overview
 Table 77. Regeneron Pharmaceuticals Cholesterol Lowering Biologic Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 78. Regeneron Pharmaceuticals Cholesterol Lowering Biologic Drugs Product
 Table 79. Regeneron Pharmaceuticals Recent Developments/Updates
 Table 80. Alnylam Pharmaceuticals Company Information
 Table 81. Alnylam Pharmaceuticals Description and Business Overview
 Table 82. Alnylam Pharmaceuticals Cholesterol Lowering Biologic Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 83. Alnylam Pharmaceuticals Cholesterol Lowering Biologic Drugs Product
 Table 84. Alnylam Pharmaceuticals Recent Developments/Updates
 Table 85. Key Raw Materials Lists
 Table 86. Raw Materials Key Suppliers Lists
 Table 87. Cholesterol Lowering Biologic Drugs Distributors List
 Table 88. Cholesterol Lowering Biologic Drugs Customers List
 Table 89. Cholesterol Lowering Biologic Drugs Market Trends
 Table 90. Cholesterol Lowering Biologic Drugs Market Drivers
 Table 91. Cholesterol Lowering Biologic Drugs Market Challenges
 Table 92. Cholesterol Lowering Biologic Drugs Market Restraints
 Table 93. Research Programs/Design for This Report
 Table 94. Key Data Information from Secondary Sources
 Table 95. Key Data Information from Primary Sources
 Table 96. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Cholesterol Lowering Biologic Drugs
 Figure 2. Global Cholesterol Lowering Biologic Drugs Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Cholesterol Lowering Biologic Drugs Market Share by Type: 2024 & 2031
 Figure 4. Oral Product Picture
 Figure 5. Injectable Product Picture
 Figure 6. Global Cholesterol Lowering Biologic Drugs Market Value by Application (2020-2031) & (US$ Million)
 Figure 7. Global Cholesterol Lowering Biologic Drugs Market Share by Application: 2024 & 2031
 Figure 8. Hospital Pharmacies
 Figure 9. Retail Pharmacies
 Figure 10. Drug Stores
 Figure 11. Online Sales
 Figure 12. Global Cholesterol Lowering Biologic Drugs Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 13. Global Cholesterol Lowering Biologic Drugs Market Size (2020-2031) & (US$ Million)
 Figure 14. Global Cholesterol Lowering Biologic Drugs Sales (2020-2031) & (K Units)
 Figure 15. Global Cholesterol Lowering Biologic Drugs Average Price (USD/Unit) & (2020-2031)
 Figure 16. Cholesterol Lowering Biologic Drugs Report Years Considered
 Figure 17. Cholesterol Lowering Biologic Drugs Sales Share by Manufacturers in 2024
 Figure 18. Global Cholesterol Lowering Biologic Drugs Revenue Share by Manufacturers in 2024
 Figure 19. Global 5 and 10 Largest Cholesterol Lowering Biologic Drugs Players: Market Share by Revenue in Cholesterol Lowering Biologic Drugs in 2024
 Figure 20. Cholesterol Lowering Biologic Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 21. Global Cholesterol Lowering Biologic Drugs Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 22. North America Cholesterol Lowering Biologic Drugs Sales Market Share by Country (2020-2031)
 Figure 23. North America Cholesterol Lowering Biologic Drugs Revenue Market Share by Country (2020-2031)
 Figure 24. U.S. Cholesterol Lowering Biologic Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 25. Canada Cholesterol Lowering Biologic Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 26. Europe Cholesterol Lowering Biologic Drugs Sales Market Share by Country (2020-2031)
 Figure 27. Europe Cholesterol Lowering Biologic Drugs Revenue Market Share by Country (2020-2031)
 Figure 28. Germany Cholesterol Lowering Biologic Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 29. France Cholesterol Lowering Biologic Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 30. U.K. Cholesterol Lowering Biologic Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 31. Italy Cholesterol Lowering Biologic Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 32. Russia Cholesterol Lowering Biologic Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 33. Asia Pacific Cholesterol Lowering Biologic Drugs Sales Market Share by Region (2020-2031)
 Figure 34. Asia Pacific Cholesterol Lowering Biologic Drugs Revenue Market Share by Region (2020-2031)
 Figure 35. China Cholesterol Lowering Biologic Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 36. Japan Cholesterol Lowering Biologic Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 37. South Korea Cholesterol Lowering Biologic Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 38. India Cholesterol Lowering Biologic Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 39. Australia Cholesterol Lowering Biologic Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 40. Taiwan Cholesterol Lowering Biologic Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 41. Indonesia Cholesterol Lowering Biologic Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 42. Thailand Cholesterol Lowering Biologic Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 43. Malaysia Cholesterol Lowering Biologic Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 44. Philippines Cholesterol Lowering Biologic Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 45. Latin America Cholesterol Lowering Biologic Drugs Sales Market Share by Country (2020-2031)
 Figure 46. Latin America Cholesterol Lowering Biologic Drugs Revenue Market Share by Country (2020-2031)
 Figure 47. Mexico Cholesterol Lowering Biologic Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 48. Brazil Cholesterol Lowering Biologic Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 49. Argentina Cholesterol Lowering Biologic Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 50. Middle East and Africa Cholesterol Lowering Biologic Drugs Sales Market Share by Country (2020-2031)
 Figure 51. Middle East and Africa Cholesterol Lowering Biologic Drugs Revenue Market Share by Country (2020-2031)
 Figure 52. Turkey Cholesterol Lowering Biologic Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 53. Saudi Arabia Cholesterol Lowering Biologic Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 54. U.A.E Cholesterol Lowering Biologic Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 55. Global Sales Market Share of Cholesterol Lowering Biologic Drugs by Type (2020-2031)
 Figure 56. Global Revenue Market Share of Cholesterol Lowering Biologic Drugs by Type (2020-2031)
 Figure 57. Global Cholesterol Lowering Biologic Drugs Price (USD/Unit) by Type (2020-2031)
 Figure 58. Global Sales Market Share of Cholesterol Lowering Biologic Drugs by Application (2020-2031)
 Figure 59. Global Revenue Market Share of Cholesterol Lowering Biologic Drugs by Application (2020-2031)
 Figure 60. Global Cholesterol Lowering Biologic Drugs Price (USD/Unit) by Application (2020-2031)
 Figure 61. Cholesterol Lowering Biologic Drugs Value Chain
 Figure 62. Channels of Distribution (Direct Vs Distribution)
 Figure 63. Bottom-up and Top-down Approaches for This Report
 Figure 64. Data Triangulation
 Figure 65. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Nano Dimension

SIMILAR REPORTS

Lipid lowering Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Cholesterol Lowering Drugs Market Research Report 2024
Cholesterol Reducer Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Biologics Drug Development Market Research Report 2024
Global Hyperlipidemia Drugs Market Research Report 2024
Pharmaceutical Grade Cholesterol Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Hyperlipidemia Prescription Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Type I Hyperlipoproteinemia Drug Market Research Report 2025
Lipid Lowering Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Cholesterol lowering Statins Market Research Report 2024
Global Biologics Drug Discovery Market Research Report 2024
Drugs to Treat Hypertriglyceridemia Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Statin Market Research Report 2024
Global PCSK9 Antagonists Market Research Report 2024
Biologic Therapeutic Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Weight Reduction Medicine Market Research Report 2024
Global PCSK9 Targeted Drugs Market Research Report 2024
Global Homozygous Familial Hypercholesterolemia Treatment Market Research Report 2024
Global Nonstatin Cholesterol Medications Market Research Report 2024
Global Hypertriglyceridemia Treatment Market Research Report 2025

RELATED REPORTS

Global Low-Density Lipoprotein Cholesterol Assay Kit Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-32E19705
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Cardiovascular Informations (CVIS) Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-10A6248
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Pulmonary Arterial Hypertension (PAH) Medicine Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-8I7059
Wed Sep 10 00:00:00 UTC 2025

Add to Cart

Global Heparin Calcium Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-15Y8668
Wed Sep 10 00:00:00 UTC 2025

Add to Cart

Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions